JM Financial is focusing on wealth management and private markets for growth. Private markets are expected to become a major business, potentially exceeding capital markets in profitability within three years. The company is allocating significant capital to private markets. This strategic shift aims to leverage existing strengths and capture new opportunities in India’s evolving financial landscape.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,